Close Menu

NEW YORK – Agilent Technologies reported after the close of the market on Wednesday that its third quarter revenues rose 6 percent year over year, thanks largely to an 11 percent increase in revenues for its diagnostics and genomics business.

For the three months ended July 31, the firm said revenues rose to $1.27 billion from $1.20 billion in Q3 2018, beating the average Wall Street estimate of $1.24 billion. The company said core revenues also grew 6 percent in Q3.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.

Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.

The UK is implementing COVID-19 testing with a 90-minute turnaround time.

In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.